Pressure Biosciences, Inc. (OTCQB: PBIO) operates within the research, development, and sale of pressure-based solutions geared towards the life sciences industry. Shares of the biosciences company are jumping 38.02%, through early trading on Thursday, August 22, 2019. Over the past month, Pressure BioSciences has seen average daily volume of 8,330 shares. However, volume of 36,029…
Aphria Inc (TSX:APHA)(NYSE:APHA) has been a surprise winner in an otherwise terrible summer for marijuana stocks, rising more than 20% after a Q4 earnings beat. The company’s financial results and its rising share price distinguish it from other marijuana stocks, which have been getting hit thanks to a combination of negative earnings and increased regulatory scrutiny.…
Last week was a rough one for Canopy Growth Corp (TSX:WEED)(NYSE:CGC). The stock had already been struggling in recent months and after the company released its first-quarter results, the stock fell even further, falling below $40 a share for the first time since January. At over $37 to finish the week, Canopy Growth is right around its…
Cannabis investors have had a rough ride in the last 12 months. Several stocks lost significant value due to regulatory issues and missing analyst target estimates. Cannabis stocks were overvalued and expensive. Shares of Cronos Group (TSX:CRON)(NASDAQ:CRON) have fallen 46% since March 2019. Despite the recent pullback, the stock has returned a mind-blowing 1,825% since…
The cannabis market has experienced a seismic shift over the past few years. Sales have grown at an exponential rate, and many of the top firms in the sector have seen their share prices skyrocket. Thankfully, it isn’t too late for those looking to profit from this rare opportunity. The cannabis industry is projected to…
CBD for ADHD, anxiety, and depression are often co-morbid. Can CBD treat all of that? More and more people are turning to CBD for their health, whether that means CBD for ADHD (Attention Deficit Hyperactivity Disorder), CBD for sports-related recovery, or something altogether different. Ask around among your friends and family, and you might find…
Survey finds majority of addiction specialists support cannabis as part of a recovery program. A study published in February of this year found that the majority of addiction specialists in America are in favor of legalizing cannabis for medicinal consumption.  Published in the journal Substance Abuse, this is the first study to look specifically at…
Vapen MJ Ventures Corporation (CSE: VAPN, OTCQX: VAPNF) a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, today reported financial results for the second quarter ended June 30, 2019. Financial Results (Comparing the three months ended June 30, 2019 to the three months ended June 30, 2018) Vapen MJ’s gross revenues increased…
After Aphria announced its financial earnings for the 2019 fiscal year this month, you might have been curious about the performance of CannTrust (TSX:TRST)(NYSE:CTST). Unfortunately, you will be bitterly disappointed by the company after it started to face problems with regulators and its stock plummeted. What happened with CannTrust? The dominoes began to fall when…
Last week was not a good one for Canopy Growth Corporation (TSX:WEED)(NYSE:CGC). After some of its competitors announced solid earnings — including a few who told investors they were profitable — Canopy Growth disappointed the market when it announced adjusted EBITDA of negative $92 million. That came on net revenue of just over $90 million,…